Dividends & Buybacks ·
Jaguar Health effects one-for-fifteen reverse split, leaving about 521K common shares outstanding
JAGXJaguar Health, Inc.
Jaguar Health, Inc. filed a Certificate of Elimination with the Delaware Secretary of State on September 15, 2026, removing Series B-2 through O preferred stock from its authorized capital as all such shares had previously been converted or disposed of. The company also announced that it effected a one-for-fifteen reverse stock split of its common stock effective September 17, 2026, resulting in approximately 520,088 outstanding shares post-split. Jaguar Health operates in the pharmaceutical industry.